Maneka Mirchandaney

Stock Analyst at Evercore ISI Group

(0.27)
# 4,404
Out of 5,154 analysts
8
Total ratings
28.57%
Success rate
-28.86%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Maneka Mirchandaney

Incyte
Mar 5, 2026
Maintains: In-Line
Price Target: $73$110
Current: $95.94
Upside: +14.65%
Crinetics Pharmaceuticals
Sep 11, 2023
Maintains: Outperform
Price Target: $41$48
Current: $38.23
Upside: +25.56%
MiNK Therapeutics
Mar 22, 2023
Maintains: Outperform
Price Target: $40$30
Current: $10.28
Upside: +191.83%
Viridian Therapeutics
Oct 12, 2021
Initiates: Outperform
Price Target: $40
Current: $28.34
Upside: +41.14%
Werewolf Therapeutics
May 25, 2021
Initiates: Outperform
Price Target: $23
Current: $0.63
Upside: +3,539.82%